Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trialKarin Hardt, Jeffrey J. Stoddard, Carla Truyers et al.|The Lancet Infectious Diseases|2022Cited by 88
Platelet-rich plasma activates AKT signaling to promote wound healing in a mouse model of radiation-induced skin injuryJanet Lee, Sehwan Shim|Journal of Translational Medicine|2019Cited by 43